本文關(guān)鍵詞：基于量表評(píng)估穩(wěn)心律合劑對(duì)長(zhǎng)程持續(xù)性及永久性心房顫動(dòng)（心陽不振證）患者的干預(yù)作用　出處：《南京中醫(yī)藥大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： 心房顫動(dòng) 穩(wěn)心律合劑 量表分析 生活質(zhì)量 臨床研究

【摘要】：目的:應(yīng)用《心房顫動(dòng)對(duì)生活質(zhì)量的影響》、《中華生存質(zhì)量量表》以及《心悸(心陽不振)證候評(píng)分表》這三個(gè)量表進(jìn)行臨床研究,初步評(píng)估醫(yī)院自制制劑"穩(wěn)心律合劑”對(duì)長(zhǎng)程持續(xù)性及永久性房顫(心悸-心陽不振型)患者治療前后生活質(zhì)量、中醫(yī)證候及心室率的影響。方法:以長(zhǎng)程持續(xù)性及永久性房顫(中醫(yī)心陽不振證)患者為研究對(duì)象,將符合納入標(biāo)準(zhǔn)的60例患者隨機(jī)分為兩組,每組各30例,在常規(guī)西藥抗凝、控制心室率等治療基礎(chǔ)上,穩(wěn)心律合劑組予以口服醫(yī)院自制制劑穩(wěn)心律合劑(20毫升,每天3次),對(duì)照組單純西藥治療。2組患者觀察周期均為28天。采用《心房顫動(dòng)對(duì)生活質(zhì)量的影響》、《中華生存質(zhì)量量表》、《心悸(心陽不振)證候?qū)W評(píng)分表》這三個(gè)量表進(jìn)行治療前后評(píng)分,觀察患者治療前后生活質(zhì)量、中醫(yī)證候及靜息心室率的變化,進(jìn)行統(tǒng)計(jì)學(xué)分析,評(píng)估其干預(yù)作用及差異性。結(jié)果:(1)《心房顫動(dòng)對(duì)生活質(zhì)量的影響》量表評(píng)估:穩(wěn)心律合劑組在"癥狀”、"日�；顒�(dòng)"、"總體評(píng)價(jià)"以及"治療滿意度”4個(gè)維度的改善與對(duì)照組相比更為明顯。兩組治療后在"治療焦慮"這一項(xiàng)維度均無明顯改善。(2)《中華生存質(zhì)量》量表評(píng)估:第一維度,與對(duì)照組相比,穩(wěn)心律合劑組在"睡眠"、"眼神"、"飲食消化"及"喜”4個(gè)維度的改善更為明顯。第二維度:與對(duì)照組相比,穩(wěn)心律合劑組在"形"這一項(xiàng)維度的改善更為明顯。(3)中醫(yī)證候積分評(píng)估:與對(duì)照組相比,穩(wěn)心律合劑組對(duì)中醫(yī)心悸(心陽不振)證候積分改善更為明顯。(4)心室率:與對(duì)照組相比,穩(wěn)心律合劑組有一定程度減慢患者心室率作用。結(jié)論:(1)醫(yī)院自制制劑"穩(wěn)心律合劑"能在一定程度上改善長(zhǎng)程持續(xù)性及永久性房顫(心悸-心陽不振證)患者的生活質(zhì)量、中醫(yī)證候,并有部分影響心室率的作用。(2)在長(zhǎng)程持續(xù)性及永久性房顫患者常規(guī)西藥治療(主要包括抗凝、控制心室率)的基礎(chǔ)上,聯(lián)合中藥穩(wěn)心律合劑進(jìn)行干預(yù),對(duì)提高患者生活質(zhì)量,改善中醫(yī)證候和臨床癥狀,作用更為明顯,優(yōu)于單純西藥治療。
[Abstract]:Objective: the effect on quality of life > < < application of atrial fibrillation, the Chinese quality of life scale > and < palpitation (Xin Yang sluggish) syndrome score table for the three scales for clinical research, preliminary evaluation of hospital preparation "steady rhythm mixture on the long persistent and permanent atrial fibrillation (palpitations - Heart Yang type) patients before and after treatment, quality of life and influence of TCM syndrome and ventricular rate. Methods: the long-term persistent and permanent atrial fibrillation (heart yang deficiency) patients as the research object, will meet the inclusion criteria of 60 patients were randomly divided into two groups, each group of 30 in conventional medicine cases, anticoagulation, ventricular rate control and treatment, steady rhythm mixture group received oral hospital preparation with stable mixture (20 ml, 3 times a day), the control group of Western medicine treatment of patients in the.2 group the observation period was 28 days. The" atrial fibrillation effect on quality of life "," the survival 璐ㄩ噺閲忚〃>,<蹇?jī)鎮(zhèn)?蹇?jī)闃充笉鎸?璇佸，

本文編號(hào)：1360152